Bausch & Lomb executive granted 10,202 share award

Bonnefoy Luc reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Bonnefoy Luc reported acquisition or exercise transactions in this Form 4 filing.

Bausch & Lomb Corp President, Surgical, Luc Bonnefoy reported an equity award involving 10,202 common shares of the company. These shares relate to performance stock units granted on March 1, 2023 that met their performance conditions as of February 18, 2026. The earned units are scheduled to vest on March 1, 2026, generally conditioned on his continued employment, bringing his reported direct holdings to 87,564 common shares.

Insider Trade Summary

Grant/Award: 10,202 shares

Grant/Award 1 txn

Insider Bonnefoy Luc

Role President, Surgical

Type	Security	Shares	Price	Value
Grant/Award	Common Shares, No Par Value	10,202	$0.00	$0.00

Holdings After Transaction: Common Shares, No Par Value — 87,564 shares (Direct)

Footnotes (1)

1. F1. Represents common shares, no par value, of Bausch + Lomb Corporation underlying an award of performance stock units ("PSUs") originally granted to the reporting person on March 1, 2023 under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan, as amended and restated, that satisfied the applicable performance conditions as of February 18, 2026. The earned PSUs will vest on March 1, 2026, subject generally to the reporting person's continued employment through such date.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Bausch & Lomb Corp (BLCO) report for Luc Bonnefoy?

Luc Bonnefoy reported acquiring rights to 10,202 Bausch & Lomb common shares. These shares relate to performance stock units that satisfied performance conditions on February 18, 2026 and are scheduled to vest on March 1, 2026, subject to continued employment.

Was the BLCO insider Form 4 for Luc Bonnefoy an open-market stock purchase or sale?

The Form 4 reflects an equity award, not an open-market trade. It records common shares underlying performance stock units granted in 2023 that earned out by February 18, 2026 and are expected to vest on March 1, 2026, subject to ongoing employment.

How many Bausch & Lomb (BLCO) shares does Luc Bonnefoy hold after this Form 4 transaction?

After the reported equity award, Luc Bonnefoy’s direct holdings are 87,564 Bausch & Lomb common shares. This figure includes the 10,202 shares underlying performance stock units that met performance conditions as of February 18, 2026, with vesting anticipated on March 1, 2026.

What are the terms of the performance stock units reported in the BLCO Form 4?

The performance stock units were originally granted on March 1, 2023 under Bausch & Lomb’s 2022 Omnibus Incentive Plan. They satisfied performance conditions as of February 18, 2026, and the earned units will vest on March 1, 2026, generally requiring continued employment through that date.

Does Luc Bonnefoy pay a purchase price for the BLCO shares in this Form 4?

No cash purchase price is listed; the transaction price per share is shown as 0.0000. This indicates the shares arise from an equity award of performance stock units, rather than an open-market purchase, with vesting tied to prior performance and continued employment.

What compensation plan governs Luc Bonnefoy’s reported BLCO performance stock units?

The performance stock units come from the Bausch & Lomb Corporation 2022 Omnibus Incentive Plan, as amended and restated. They were granted on March 1, 2023 and later met performance conditions, with earned units scheduled to vest on March 1, 2026, assuming continued employment.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/20/2026 - 04:42 PM EST Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Bonnefoy Luc

(Last) (First) (Middle)

C/O BAUSCH + LOMB CORPORATION

520 APPLEWOOD CRESCENT

(Street)

VAUGHAN A6 L4K 4B4

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Bausch & Lomb Corp [ BLCO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President, Surgical

3. Date of Earliest Transaction (Month/Day/Year)
02/18/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Shares, No Par Value	02/18/2026		A		10,202(1)	A	$0	87,564	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents common shares, no par value, of Bausch + Lomb Corporation underlying an award of performance stock units ("PSUs") originally granted to the reporting person on March 1, 2023 under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan, as amended and restated, that satisfied the applicable performance conditions as of February 18, 2026. The earned PSUs will vest on March 1, 2026, subject generally to the reporting person's continued employment through such date.

	/s/ Debra E. Levin, attorney-in-fact	02/20/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.